A New Approach page top left image

LDDN Projects

 

Project

Project Status

1

2

3

4

5

6

7

1

Inhibitors of cdk5/p25-Catalyzed Phosphorylation of Tau

 X

 X

 X

 X

 X

X

X

2

Activators of Peptide-Exchange on MHC II

X

X

X

X

X

X

X

3

Inhibitors of EphB3 Kinase (Yr1)a

X

X

X

X

X

X

X

4

Expression of Survival Motor Neuron (SMN)

X

X

X

X

X

X

X

5

Activation of Glu Transporter EAAT2 Expression (Yr2)

X

X

X

X

X

X

X

6

Activators of Atoh1 (Yr2)

X

X

X

X

X

X

 

7

Inhibition of STEP (Yr3)

X

X

X

X

X

X

 X

8

Inhibition of BACE1 in Neuronal Cells (Yr3)

X

X

X

X

X

X

 

9

Inhibition of Kinase & GTPase Activities of LRRK2 (Yr3)

X

X

X

X

 X

   

10

Enhancers of Expression of BRCA1 (Yr3)

X

X

X

X

X


 

11

Activators of Klotho 

X

 X

 X

 X

     

12

Inhibition of Interaction between mSOD1 and Dynein (Yr4)

X






 

13

Inhibition of Ero1 Sulfhydryl Oxidase (Yr4)

X

X

X

X

     

14

Activators of PGC-1a (Yr4)

X

X

X

X




  15

Inhibition of Lyn Kinase (Yr4)

 X

           

  16

Inhibitors of APP dimerization (Yr4)

 X

 

         

  17

Stimulation of Microglia Generation (CADDIb)

 X

           

  18

Inhibition of TDP-43 Generation (CADDI)

 X

           

19

Modulators of the Expression of B-Synuclein


dormantc

20

Modulators of Insulin-Degrading Enzyme

  21

Modulators of UCH-L1 Activity

  22

Inhibitors of Tissue Transglutaminase

  23

Inhibitors of Processing of Amyloid-B Precursor

  24

Necrosis Inhibitors

         licensed IP

 

(a) Year of participation of post-doctoral fellow in the NIH-funded National Center for Drug Discovery in Neurodegeneration (Yr1 was from Fall 2005 – Fall 2006).
(b) Project sponsored by the Collaborative ALS Drug Discovery Initiative (CADDI).
(c) Dormant projects have shown good performance in HTS, but have not produced a lead structure.

Key for Status

  • Assay development is underway.
  • Assay has been developed and validated.
  • Assay development complete; shaded 'X' signifies screen underway.
  • Hits were discovered during screen.
  • Screening hits were validated and medicinal chemistry is pending.
  • Medicinal chemistry program has been launched.
  • Animal efficacy or pharmacokinetic studies.

Download a PDF of project details here.